📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical's GHG Emissions Data Preview
In 2024, Apeloa Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Apeloa Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Apeloa Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Apeloa Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Apeloa Pharmaceutical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofApeloa Pharmaceutical amounted to615,600metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Apeloa Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Apeloa Pharmaceutical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Apeloa Pharmaceutical were 10,400 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
What are Apeloa Pharmaceutical's Scope 2 emissions?
In 2024, Apeloa Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 605,200 tCOâ‚‚e without specifying the calculation method.a
What methodology does Apeloa Pharmaceutical use for Scope 2 reporting?
In 2024, Apeloa Pharmaceutical reported its Scope 2 emissions using an unspecified methodology.a
Apeloa Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Apeloa Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Apeloa Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 10,400 tCOâ‚‚e and total revenues of USD 1,647 millions. This translates into an emissions intensity of 6.31 tCOâ‚‚e per millions USD.a
Apeloa Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers
How does Apeloa Pharmaceutical's GHG emissions intensity compare to its peers?
In 2024, Apeloa Pharmaceutical reported a Scope 1 emissions intensity of 6.31 tCOâ‚‚e per millions USD. Compared to the peer group median of 25.27, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Apeloa Pharmaceutical rank on GHG emissions intensity within its industry?
In 2024, Apeloa Pharmaceutical ranked 7 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Apeloa Pharmaceutical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a